The last 4–5 years have ushered in a new era in hematological malignancies therapy, with the advent and approval of multiple novel agents, between which CAR-T cell approaches are playing a important role.
At the same time, there is an increasing under- standing of tumor biology, creating the rationale for new combinations of drugs and new therapy development.
The numerous ongoing trials evaluating the role of CAR-T in different tumors, with well-designed correlative interrogations of the immune system in patients treated in such trials, will further enhance our understanding of these new opportunities.
In this scenario, our aim is to create a internation- al team, integrating a big faculty composed by international experts, which will integrate with a group of young researchers with known experi- ence in this disease (“SOHO CAR-T cantera”), in order to share projects and preclinical and clini- cal new clinical trials, in different fields of these heterogeneous diseases.
Call for Abstracts
– biology of CAR-T
– CAR-T Clinical Projects
– CAR-T Real Life experiences
– CAR-T Related supportive care
The selected abstracs will be published by Hematology Re- ports, our official journal, and the best abstract could win a FREE REGISTRATION at SOHO ANNUAL CONFERENCE in September 2022 in Houston.